Adalimumab vs Raltegravir

## Adalimumab vs Raltegravir: Overview

This comparison examines the pharmacological differences between **Adalimumab** and **Raltegravir**.

## Mechanism of Action

**Adalimumab**: Fully human anti-TNF-alpha monoclonal antibody.

## Pharmacokinetics

**Half-life**: Adalimumab — 14 days; Raltegravir — N/A.

## Chemical Properties

**Type**: Adalimumab — Antibody; Raltegravir — Small molecule.